Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Drug risk during pregnancy

Sinha, D.N.; Huxham, I.M.

Journal of the Indian Medical Association 83(4): 117-120

1985

ISSN/ISBN: 0019-5847
PMID: 4078326
Document Number: 4011
The birth of a foetus is always at risk due to the teratogenic insult, right from the day of conception. The drugs, chemicals and infections may reach the developing "conceptus" through placenta and may influence the phenomenon of organogenesis, histogenesis and maturation process. Medical staffs, working, in this field, should remain fully aware of the risk of prescribing drugs/chemicals to prevent an unnecessary tragedy due to malformations (intrauterine death, malformations, retarted growth and functional deficit). Each prescription related to pregnant mothers needs to be checked individually as a safeguard (preventive aspects). Drug manufacturers should follow the internationally accepted criteria during the evaluation of drug/chemical for its teratogenicity.

Document emailed within 1 workday
Secure & encrypted payments

Drug risk during pregnancy

Ritchie, H.; Bolton, P. 2000: The Australian categorisation of risk of drug use in pregnancy Australian Family Physician 29(3): 237-241
Everett, B.G.; Turner, B.; Hughes, T.L.; Veldhuis, C.B.; Paschen-Wolff, M.; Phillips, G. 2019: Sexual Orientation Disparities in Pregnancy Risk Behaviors and Pregnancy Among Sexually Active Teenage Girls: Updates from the Youth Risk Behavior Survey Lgbt Health 6(7): 342-349
Trumbo, P.R.; Ellwood, K.C. 2007: Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration Nutrition Reviews 65(2): 78-87
Mosonyi, A.; Tímár, L.; Czeizel, E. 1997: Timing of attempted suicide by drug poisoning during pregnancy and pregnancy outcome Orvosi Hetilap 138(39): 2467-2470
Levy, A.; Matok, I.; Gorodischer, R.; Sherf, M.; Wiznitzer, A.; Uziel, E.; Koren, G. 2012: Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists Journal of Clinical Pharmacology 52(1): 78-83
Bresnahan, K.; Zuckerman, B.; Cabral, H. 1992: Psychosocial correlates of drug and heavy alcohol use among pregnant women at risk for drug use Obstetrics and Gynecology 80(6): 976-980
Raichel, L.; Sheiner, E. 2005: Maternal obesity as a risk factor for complications in pregnancy, labor and pregnancy outcomes Harefuah 144(2): 107-111; 150
Weiss, P.; Mark, P.M. 1997: Routine screening during pregnancy. the new Minnesota Pregnancy Risk Assessment Form Minnesota Medicine 80(12): 48-49
Guilamo-Ramos, V.; Lee, J.J.; Ruiz, Y.; Hagan, H.; Delva, M.; Quiñones, Z.; Kamler, A.; Robles, G. 2015: Illicit drug use and HIV risk in the Dominican Republic: tourism areas create drug use opportunities Global Public Health 10(3): 318-330
Deiss, R.G.; Brouwer, K.C.; Loza, O.; Lozada, R.M.; Ramos, R.; Cruz, M.A.F.; Patterson, T.L.; Heckathorn, D.D.; Frost, S.D.; Strathdee, S.A. 2008: High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities Sexually Transmitted Diseases 35(3): 243-249
Schumann, K. 1981: SP-1: parameter for the high risk pregnancy. the pregnancy specific beta 1-glycoprotein in the serum of pregnant women with toxemia Fortschritte der Medizin 99(6): 188-191
Meade, C.S.; Ickovics, J.R. 2005: Systematic review of sexual risk among pregnant and mothering teens in the USA: pregnancy as an opportunity for integrated prevention of STD and repeat pregnancy Social Science and Medicine 60(4): 661-678
Du, M.; Liu, J.; Han, N.; Zhao, Z.; Yang, J.; Xu, X.; Luo, S.; Wang, H. 2021: Maternal sleep quality during early pregnancy, risk factors and its impact on pregnancy outcomes: a prospective cohort study Sleep Medicine 79: 11-18
Chen, H.T.; Tuner, N.; Chen, C.J.; Lin, H.-y.; Liang, S.; Wang, S. 2013: Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China Aids Education and Prevention: Official Publication of the International Society for Aids Education 25(4): 336-348
Sibthorpe, B.; Fleming, D.; Gould, J. 1994: Self-help groups: a key to HIV risk reduction for high-risk injection drug users? Journal of Acquired Immune Deficiency Syndromes 7(6): 592-598
Coste, J.; Bouyer, J.; Fernandez, H.; Job-Spira, N. 1998: Predicting the risk of extra-uterine pregnancy. Construction and validation of a French risk scale Contraception Fertilite Sexualite 26(9): 643-648
Kijak, G.H.; Beyrer, C.; Tovanabutra, S.; Sripaipan, T.; Suriyanon, V.; Moqueet, N.; Sanders-Buell, E.; Saokhieo, P.; Timpan, U.; Jittiwutikarn, J.; Robb, M.L.; Birx, D.L.; Celentano, D.D.; McCutchan, F.E. 2011: Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity Drug and Alcohol Dependence 116(1-3): 24-30
Johnston, L.G.; Holman, A.; Dahoma, M.; Miller, L.A.; Kim, E.; Mussa, M.; Othman, A.A.; Kim, A.; Kendall, C.; Sabin, K. 2010: HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania International Journal on Drug Policy 21(6): 485-492
Trenholm, C.; Devaney, B.; Fortson, K.; Clark, M.; Bridgespan, L.Q.; Wheeler, J. 2008: Impacts of abstinence education on teen sexual activity, risk of pregnancy, and risk of sexually transmitted diseases Journal of Policy Analysis and Management: 27(2): 255-276
Syvertsen, J.L.; Robertson, A.M.; Strathdee, S.A.; Martinez, G.; Rangel, M.G.; Wagner, K.D. 2014: Rethinking risk: gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border International Journal on Drug Policy 25(5): 836-844